| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| Delaware | 82-0572194 | ||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
| 320 Park Avenue, | 29th Floor, | ||||||||||
| New York, | New York | 10022 | |||||||||
| (Address of principal executive offices) | (Zip code) | ||||||||||
| Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of Each Class: | Trading symbol(s) | Name of Each Exchange on Which Registered: | ||||||
| Common Stock, par value $0.001 per share | EXLS | The Nasdaq Stock Market LLC | ||||||
| Large Accelerated Filer | ☒ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ | |||||||||||||||||||
| PAGE | |||||||||||
| ITEM | |||||||||||
| 1. | |||||||||||
| 2. | |||||||||||
| 3. | |||||||||||
| 4. | |||||||||||
| 1. | |||||||||||
| 1A. | |||||||||||
| 2. | |||||||||||
| 3. | |||||||||||
| 4. | |||||||||||
| 5. | |||||||||||
| 6. | |||||||||||
| As of | |||||||||||||||||
| Notes | June 30, 2026 | December 31, 2025 | |||||||||||||||
| Assets | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | 7 | $ | 126,722 | $ | 146,326 | ||||||||||||
| Short-term investments | 8 | 157,102 | 182,041 | ||||||||||||||
| Restricted cash | 7 | 12,964 | 12,392 | ||||||||||||||
| Accounts receivable, net | 4 | 434,362 | 343,105 | ||||||||||||||
| Other current assets | 11 | 144,132 | 146,093 | ||||||||||||||
| Total current assets | 875,282 | 829,957 | |||||||||||||||
| Property and equipment, net | 9 | 114,587 | 111,821 | ||||||||||||||
| Operating lease right-of-use assets | 21 | 97,495 | 97,411 | ||||||||||||||
| Restricted cash | 7 | 7,086 | 7,251 | ||||||||||||||
| Deferred tax assets, net | 22 | 139,288 | 129,968 | ||||||||||||||
| Goodwill | 10 | 418,693 | 419,654 | ||||||||||||||
| Other intangible assets, net | 10 | 29,720 | 36,204 | ||||||||||||||
| Long-term investments | 8 | 6,396 | 8,198 | ||||||||||||||
| Other assets | 12 | 59,340 | 61,771 | ||||||||||||||
| Total assets | $ | 1,747,887 | $ | 1,702,235 | |||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable | $ | 6,733 | $ | 4,753 | |||||||||||||
| Current portion of long-term borrowings | 18 | 381,155 | 4,886 | ||||||||||||||
| Deferred revenue | 22,591 | 15,356 | |||||||||||||||
| Accrued employee costs | 112,908 | 146,775 | |||||||||||||||
| Accrued expenses and other current liabilities | 13 | 161,525 | 135,498 | ||||||||||||||
| Current portion of operating lease liabilities | 21 | 18,734 | 16,857 | ||||||||||||||
| Total current liabilities | 703,646 | 324,125 | |||||||||||||||
| Long-term borrowings, less current portion | 18 | — | 293,712 | ||||||||||||||
| Operating lease liabilities, less current portion | 21 | 88,130 | 88,167 | ||||||||||||||
| Deferred tax liabilities, net | 22 | 2,256 | 2,125 | ||||||||||||||
| Other non-current liabilities | 14 | 87,613 | 81,401 | ||||||||||||||
| Total liabilities | 881,645 | 789,530 | |||||||||||||||
| Commitments and contingencies | 25 | ||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||
Preferred stock, $0.001 par value; 15,000,000 shares authorized, none issued | — | — | |||||||||||||||
Common stock, $0.001 par value; 400,000,000 shares authorized, 210,101,885 shares issued and 151,745,072 shares outstanding as of June 30, 2026 and 208,855,566 shares issued and 156,430,028 shares outstanding as of December 31, 2025 | 19 | 210 | 209 | ||||||||||||||
| Additional paid-in capital | 724,432 | 677,562 | |||||||||||||||
| Retained earnings | 1,664,571 | 1,532,979 | |||||||||||||||
| Accumulated other comprehensive loss | 15 | (223,682) | (180,727) | ||||||||||||||
| Total including shares held in treasury | 2,165,531 | 2,030,023 | |||||||||||||||
Less: 58,356,813 shares as of June 30, 2026 and 52,425,538 shares as of December 31, 2025, held in treasury, at cost | 19 | (1,299,289) | (1,117,318) | ||||||||||||||
| Total stockholders’ equity | 866,242 | 912,705 | |||||||||||||||
| Total liabilities and stockholders’ equity | $ | 1,747,887 | $ | 1,702,235 | |||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||||||||
| Notes | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| Revenues, net | 3, 4 | $ | 594,763 | $ | 514,460 | $ | 1,165,114 | $ | 1,015,479 | ||||||||||||||||||||
Cost of revenues(1) | 368,800 | 320,272 | 717,070 | 627,977 | |||||||||||||||||||||||||
Gross profit(1) | 225,963 | 194,188 | 448,044 | 387,502 | |||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||
| General and administrative expenses | 74,436 | 59,549 | 143,487 | 118,966 | |||||||||||||||||||||||||
| Selling and marketing expenses | 49,628 | 39,446 | 96,829 | 81,371 | |||||||||||||||||||||||||
| Depreciation and amortization expense | 9, 10 | 14,604 | 14,055 | 28,607 | 27,612 | ||||||||||||||||||||||||
| Total operating expenses | 138,668 | 113,050 | 268,923 | 227,949 | |||||||||||||||||||||||||
| Income from operations | 87,295 | 81,138 | 179,121 | 159,553 | |||||||||||||||||||||||||
| Foreign exchange gain, net | 1,609 | 2,211 | 2,744 | 3,403 | |||||||||||||||||||||||||
| Interest expense | 18 | (5,068) | (4,282) | (9,019) | (8,426) | ||||||||||||||||||||||||
| Other income, net | 6 | 130 | 5,671 | 2,521 | 10,374 | ||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | 83,966 | 84,738 | 175,367 | 164,904 | |||||||||||||||||||||||||
| Income tax expense | 22 | 19,426 | 18,546 | 43,744 | 32,042 | ||||||||||||||||||||||||
| Income before earnings from equity affiliates | 64,540 | 66,192 | 131,623 | 132,862 | |||||||||||||||||||||||||
| Loss from equity-method investment | (29) | (141) | (31) | (250) | |||||||||||||||||||||||||
| Net income | $ | 64,511 | $ | 66,051 | $ | 131,592 | $ | 132,612 | |||||||||||||||||||||
| Earnings per share: | 5 | ||||||||||||||||||||||||||||
| Basic | $ | 0.42 | $ | 0.41 | $ | 0.85 | $ | 0.82 | |||||||||||||||||||||
| Diluted | $ | 0.42 | $ | 0.40 | $ | 0.85 | $ | 0.81 | |||||||||||||||||||||
| Weighted average number of shares used in computing earnings per share: | 5 | ||||||||||||||||||||||||||||
| Basic | 152,554,401 | 162,925,484 | 154,292,120 | 162,709,034 | |||||||||||||||||||||||||
| Diluted | 152,831,994 | 164,193,258 | 154,858,444 | 164,376,498 | |||||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||||||||
| Notes | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| Net income | $ | 64,511 | $ | 66,051 | $ | 131,592 | $ | 132,612 | |||||||||||||||||||||
| Other comprehensive income/(loss): | |||||||||||||||||||||||||||||
| Unrealized gain/(loss) on cash flow hedges | 17 | 8,888 | 5,955 | (37,047) | 15,424 | ||||||||||||||||||||||||
| Retirement benefits | 20 | — | — | (1,177) | — | ||||||||||||||||||||||||
| Currency translation adjustments | 713 | 4,006 | (23,091) | 7,933 | |||||||||||||||||||||||||
| Reclassification adjustments: | |||||||||||||||||||||||||||||
(Gain)/loss on cash flow hedges(1) | 17 | 7,807 | (554) | 12,729 | 1,044 | ||||||||||||||||||||||||
Retirement benefits(2) | 20 | 405 | (117) | 743 | (228) | ||||||||||||||||||||||||
Income tax effects relating to above(3) | 22 | (4,121) | (937) | 4,888 | (3,885) | ||||||||||||||||||||||||
| Total other comprehensive income/(loss) | 13,692 | 8,353 | (42,955) | 20,288 | |||||||||||||||||||||||||
| Total comprehensive income | $ | 78,203 | $ | 74,404 | $ | 88,637 | $ | 152,900 | |||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income/(loss) | Treasury Stock | Total | ||||||||||||||||||||||||||||||||||||||||||||||||
| Notes | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2026 | 209,929,764 | $ | 210 | $ | 674,662 | $ | 1,600,060 | $ | (237,374) | (56,930,339) | $ | (1,258,754) | $ | 778,804 | |||||||||||||||||||||||||||||||||||||||
| Stock issued against stock-based compensation plans | 23 | 172,121 | — | 3,412 | — | — | — | — | 3,412 | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 23 | — | — | 24,631 | — | — | — | — | 24,631 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition of treasury stock | 19 | — | — | — | — | — | (626,514) | (18,451) | (18,451) | ||||||||||||||||||||||||||||||||||||||||||||
| Accelerated share repurchases | 5, 19 | — | — | 21,727 | — | — | (799,960) | (21,727) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Excise tax on repurchase of common stock, net of stock issuances | 19 | — | — | — | — | — | — | (357) | (357) | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | 15 | — | — | — | — | 13,692 | — | — | 13,692 | ||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | 64,511 | — | — | — | 64,511 | |||||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2026 | 210,101,885 | $ | 210 | $ | 724,432 | $ | 1,664,571 | $ | (223,682) | (58,356,813) | $ | (1,299,289) | $ | 866,242 | |||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income/(loss) | Treasury Stock | Total | ||||||||||||||||||||||||||||||||||||||||||||||||
| Notes | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2025 | 207,758,497 | $ | 207 | $ | 609,592 | $ | 1,348,521 | $ | (142,787) | (45,075,154) | $ | (803,656) | $ | 1,011,877 | |||||||||||||||||||||||||||||||||||||||
| Stock issued against stock-based compensation plans | 23 | 52,138 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 23 | — | — | 16,392 | — | — | — | — | 16,392 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition of treasury stock | 19 | — | — | — | — | — | (906,150) | (41,752) | (41,752) | ||||||||||||||||||||||||||||||||||||||||||||
| Excise tax on repurchase of common stock, net of stock issuances | 19 | — | — | — | — | — | — | 29 | 29 | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | 15 | — | — | — | — | 8,353 | — | — | 8,353 | ||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | 66,051 | — | — | — | 66,051 | |||||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2025 | 207,810,635 | $ | 207 | $ | 625,984 | $ | 1,414,572 | $ | (134,434) | (45,981,304) | $ | (845,379) | $ | 1,060,950 | |||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income/(loss) | Treasury Stock | Total | ||||||||||||||||||||||||||||||||||||||||||||||||
| Notes | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2025 | 208,855,566 | $ | 209 | $ | 677,562 | $ | 1,532,979 | $ | (180,727) | (52,425,538) | $ | (1,117,318) | $ | 912,705 | |||||||||||||||||||||||||||||||||||||||
| Stock issued against stock-based compensation plans | 23 | 1,246,319 | 1 | 3,411 | — | — | — | — | 3,412 | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 23 | — | — | 46,732 | — | — | — | — | 46,732 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition of treasury stock | 19 | — | — | — | — | — | (1,784,595) | (59,101) | (59,101) | ||||||||||||||||||||||||||||||||||||||||||||
| Accelerated share repurchases | 5, 19 | — | — | (3,273) | — | — | (4,146,680) | (121,727) | (125,000) | ||||||||||||||||||||||||||||||||||||||||||||
| Excise tax on repurchase of common stock, net of stock issuances | 19 | — | — | — | — | — | — | (1,143) | (1,143) | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | 15 | — | — | — | — | (42,955) | — | — | (42,955) | ||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | 131,592 | — | — | — | 131,592 | |||||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2026 | 210,101,885 | $ | 210 | $ | 724,432 | $ | 1,664,571 | $ | (223,682) | (58,356,813) | $ | (1,299,289) | $ | 866,242 | |||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income/(loss) | Treasury Stock | Total | ||||||||||||||||||||||||||||||||||||||||||||||||
| Notes | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2024 | 206,510,587 | $ | 206 | $ | 588,583 | $ | 1,281,960 | $ | (154,722) | (44,709,375) | $ | (786,165) | $ | 929,862 | |||||||||||||||||||||||||||||||||||||||
| Stock issued against stock-based compensation plans | 23 | 1,300,048 | 1 | 1,822 | — | — | — | — | 1,823 | ||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 23 | — | — | 35,579 | — | — | — | — | 35,579 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition of treasury stock | 19 | — | — | — | — | — | (1,271,929) | (59,243) | (59,243) | ||||||||||||||||||||||||||||||||||||||||||||
| Excise tax on repurchase of common stock, net of stock issuances | 19 | — | — | — | — | — | — | 29 | 29 | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | 15 | — | — | — | — | 20,288 | — | — | 20,288 | ||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | 132,612 | — | — | — | 132,612 | |||||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2025 | 207,810,635 | $ | 207 | $ | 625,984 | $ | 1,414,572 | $ | (134,434) | (45,981,304) | $ | (845,379) | $ | 1,060,950 | |||||||||||||||||||||||||||||||||||||||
| Six months ended June 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 131,592 | $ | 132,612 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization expense | 28,473 | 27,689 | |||||||||
| Stock-based compensation expense | 46,732 | 35,579 | |||||||||
| Reduction in the carrying amount of operating lease right-of-use assets | 14,018 | 12,489 | |||||||||
| Fair value mark-to-market on investments | (3,054) | (1,304) | |||||||||
| Unrealized foreign currency exchange (gain)/loss, net | (11,412) | (3,314) | |||||||||
| Deferred income tax benefit | (4,930) | (15,605) | |||||||||
| Others, net | 4,315 | 1,581 | |||||||||
| Change in operating assets and liabilities: | |||||||||||
| Accounts receivable | (93,298) | (38,312) | |||||||||
| Other current and non-current assets | (27,781) | (10,434) | |||||||||
| Income taxes payable, net | 31,392 | 4,202 | |||||||||
| Deferred revenue | 7,303 | 2,426 | |||||||||
| Accrued employee costs | (29,637) | (31,278) | |||||||||
| Accounts payable, accrued expenses and other liabilities | 7,940 | 8,539 | |||||||||
| Operating lease liabilities | (12,042) | (12,250) | |||||||||
| Net cash provided by operating activities | 89,611 | 112,620 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property and equipment | (27,440) | (27,366) | |||||||||
| Proceeds from sale of property and equipment | 166 | 180 | |||||||||
| Purchases of investments | (137,311) | (144,935) | |||||||||
| Proceeds from redemption of investments | 158,999 | 136,434 | |||||||||
| Investment in equity affiliate | (600) | (600) | |||||||||
| Net cash used for investing activities | (6,186) | (36,287) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Principal payments of finance lease liabilities | (277) | (247) | |||||||||
| Proceeds from borrowings | 175,000 | 50,000 | |||||||||
| Repayments of borrowings | (92,500) | (78,500) | |||||||||
| Acquisition of treasury stock | (186,605) | (59,673) | |||||||||
| Proceeds from issuance of common stock | 3,620 | 3,868 | |||||||||
| Net cash used for financing activities | (100,762) | (84,552) | |||||||||
| Effect of exchange rate changes | (1,860) | 7,346 | |||||||||
| Net decrease in cash, cash equivalents and restricted cash | (19,197) | (873) | |||||||||
| Cash, cash equivalents and restricted cash at the beginning of the period | 165,969 | 171,398 | |||||||||
| Cash, cash equivalents and restricted cash at the end of the period | $ | 146,772 | $ | 170,525 | |||||||
| Supplemental disclosure of cash flow information: | |||||||||||
| Cash paid during the period for: | |||||||||||
| Interest | $ | 8,934 | $ | 8,216 | |||||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||||||
| Additions to property and equipment not yet paid | $ | 3,294 | $ | 6,186 | |||||||
| Assets acquired under finance lease | $ | 383 | $ | 633 | |||||||
| Three months ended June 30, 2026 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 197,783 | $ | 157,968 | $ | 133,856 | $ | 105,156 | $ | 594,763 | |||||||||||||||||||
Cost of revenues(1) | |||||||||||||||||||||||||||||
| Employee costs | 105,992 | 66,942 | 73,415 | 54,530 | 300,879 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 15,532 | 8,665 | 8,550 | 10,939 | 43,686 | ||||||||||||||||||||||||
Other costs(2) | 7,865 | 8,316 | 5,284 | 2,770 | 24,235 | ||||||||||||||||||||||||
Gross profit(1) | $ | 68,394 | $ | 74,045 | $ | 46,607 | $ | 36,917 | $ | 225,963 | |||||||||||||||||||
| Operating expenses | 138,668 | ||||||||||||||||||||||||||||
| Income from operations | 87,295 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | (3,329) | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 83,966 | |||||||||||||||||||||||||||
| Three months ended June 30, 2025 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 172,174 | $ | 129,489 | $ | 121,089 | $ | 91,708 | $ | 514,460 | |||||||||||||||||||
Cost of revenues(1) | |||||||||||||||||||||||||||||
| Employee costs | 95,370 | 60,972 | 66,158 | 49,637 | 272,137 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 13,380 | 7,067 | 6,367 | 8,294 | 35,108 | ||||||||||||||||||||||||
Other costs(2) | 3,558 | 5,066 | 2,845 | 1,558 | 13,027 | ||||||||||||||||||||||||
Gross profit(1) | $ | 59,866 | $ | 56,384 | $ | 45,719 | $ | 32,219 | $ | 194,188 | |||||||||||||||||||
| Operating expenses | 113,050 | ||||||||||||||||||||||||||||
| Income from operations | 81,138 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | 3,600 | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 84,738 | |||||||||||||||||||||||||||
| Six months ended June 30, 2026 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 391,713 | $ | 309,888 | $ | 261,249 | $ | 202,264 | $ | 1,165,114 | |||||||||||||||||||
Cost of revenues(1) | |||||||||||||||||||||||||||||
| Employee costs | 205,921 | 133,828 | 142,632 | 106,299 | 588,680 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 30,547 | 17,090 | 16,065 | 21,222 | 84,924 | ||||||||||||||||||||||||
Other costs(2) | 13,723 | 16,113 | 8,946 | 4,684 | 43,466 | ||||||||||||||||||||||||
Gross profit(1) | $ | 141,522 | $ | 142,857 | $ | 93,606 | $ | 70,059 | $ | 448,044 | |||||||||||||||||||
| Operating expenses | 268,923 | ||||||||||||||||||||||||||||
| Income from operations | 179,121 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | (3,754) | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 175,367 | |||||||||||||||||||||||||||
| Six months ended June 30, 2025 | |||||||||||||||||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Revenues, net | $ | 344,230 | $ | 255,081 | $ | 238,791 | $ | 177,377 | $ | 1,015,479 | |||||||||||||||||||
Cost of revenues(1) | |||||||||||||||||||||||||||||
| Employee costs | 185,919 | 119,896 | 130,452 | 94,457 | 530,724 | ||||||||||||||||||||||||
| Infrastructure and technology costs | 26,626 | 13,805 | 12,536 | 16,455 | 69,422 | ||||||||||||||||||||||||
Other costs(2) | 8,930 | 9,916 | 6,131 | 2,854 | 27,831 | ||||||||||||||||||||||||
Gross profit(1) | $ | 122,755 | $ | 111,464 | $ | 89,672 | $ | 63,611 | $ | 387,502 | |||||||||||||||||||
| Operating expenses | 227,949 | ||||||||||||||||||||||||||||
| Income from operations | 159,553 | ||||||||||||||||||||||||||||
| Foreign exchange gain, net, interest expense and other income, net | 5,351 | ||||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | $ | 164,904 | |||||||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
Data and AI-led(1) | $ | 362,558 | $ | 278,770 | $ | 704,180 | $ | 546,699 | |||||||||||||||
Digital operations(2) | 232,205 | 235,690 | 460,934 | 468,780 | |||||||||||||||||||
| Revenues, net | $ | 594,763 | $ | 514,460 | $ | 1,165,114 | $ | 1,015,479 | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues, net | |||||||||||||||||||||||
| North America | $ | 489,593 | $ | 422,822 | $ | 962,736 | $ | 838,171 | |||||||||||||||
| United Kingdom & Europe | 89,403 | 77,635 | 171,921 | 150,019 | |||||||||||||||||||
| Rest of World | 15,767 | 14,003 | 30,457 | 27,289 | |||||||||||||||||||
| Revenues, net | $ | 594,763 | $ | 514,460 | $ | 1,165,114 | $ | 1,015,479 | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Insurance | $ | 233,701 | $ | 203,222 | $ | 459,761 | $ | 403,583 | |||||||||||||||
| Healthcare and Life Sciences | 158,257 | 129,737 | 310,372 | 255,563 | |||||||||||||||||||
| Banking, Capital Markets and Diversified Industries | 202,805 | 181,501 | 394,981 | 356,333 | |||||||||||||||||||
| Revenues, net | $ | 594,763 | $ | 514,460 | $ | 1,165,114 | $ | 1,015,479 | |||||||||||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Long-lived assets | |||||||||||
| India | $ | 69,188 | $ | 63,999 | |||||||
| North America | 55,884 | 60,575 | |||||||||
| The Philippines | 34,977 | 36,480 | |||||||||
| South Africa | 18,456 | 19,635 | |||||||||
| Rest of World | 33,577 | 28,543 | |||||||||
| Long-lived assets | $ | 212,082 | $ | 209,232 | |||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Accounts receivable, net | $ | 434,362 | $ | 343,105 | |||||||
| Contract assets | $ | 43,281 | $ | 31,901 | |||||||
| Contract liabilities: | |||||||||||
| Deferred revenue (consideration received in advance) | $ | 14,327 | $ | 9,216 | |||||||
| Consideration received for process transition activities | $ | 33,761 | $ | 32,247 | |||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Deferred revenue (consideration received in advance) | $ | 1,883 | $ | 3,877 | $ | 6,498 | $ | 11,306 | |||||||||||||||
| Consideration received for process transition activities | $ | 1,932 | $ | 1,279 | $ | 3,924 | $ | 2,656 | |||||||||||||||
| Contract Acquisition Costs | |||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Opening balance | $ | 1,766 | $ | 2,126 | $ | 1,947 | $ | 2,287 | |||||||||||||||
| Additions | — | 284 | — | 365 | |||||||||||||||||||
| Amortization | (160) | (218) | (341) | (460) | |||||||||||||||||||
| Closing balance | $ | 1,606 | $ | 2,192 | $ | 1,606 | $ | 2,192 | |||||||||||||||
| Contract Fulfillment Costs | |||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Opening balance | $ | 38,387 | $ | 38,080 | $ | 39,223 | $ | 36,022 | |||||||||||||||
| Additions | 2,210 | 2,156 | 3,174 | 5,485 | |||||||||||||||||||
| Amortization | (1,976) | (1,298) | (3,776) | (2,569) | |||||||||||||||||||
| Closing balance | $ | 38,621 | $ | 38,938 | $ | 38,621 | $ | 38,938 | |||||||||||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Accounts receivable, including unbilled receivables | $ | 437,643 | $ | 345,980 | |||||||
| Less: Allowance for expected credit losses | (3,281) | (2,875) | |||||||||
| Accounts receivable, net | $ | 434,362 | $ | 343,105 | |||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Opening balance | $ | 3,065 | $ | 4,734 | $ | 2,875 | $ | 3,528 | |||||||||||||||
| Additions | 266 | 29 | 516 | 1,248 | |||||||||||||||||||
| Reductions due to write-off of accounts receivable | (50) | (34) | (111) | (47) | |||||||||||||||||||
| Currency translation adjustments | — | (2) | 1 | (2) | |||||||||||||||||||
| Closing balance | $ | 3,281 | $ | 4,727 | $ | 3,281 | $ | 4,727 | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
| Net income | $ | 64,511 | $ | 66,051 | $ | 131,592 | $ | 132,612 | |||||||||||||||
| Denominator: | |||||||||||||||||||||||
| Basic weighted average common shares outstanding | 152,554,401 | 162,925,484 | 154,292,120 | 162,709,034 | |||||||||||||||||||
| Dilutive effect of stock-based awards | 277,593 | 1,267,774 | 566,324 | 1,667,464 | |||||||||||||||||||
| Diluted weighted average common shares outstanding | 152,831,994 | 164,193,258 | 154,858,444 | 164,376,498 | |||||||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ | 0.42 | $ | 0.41 | $ | 0.85 | $ | 0.82 | |||||||||||||||
| Diluted | $ | 0.42 | $ | 0.40 | $ | 0.85 | $ | 0.81 | |||||||||||||||
| Weighted average potentially dilutive shares considered anti-dilutive and not included in computing diluted earnings per share | 2,440,204 | 728,203 | 2,028,225 | 523,472 | |||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Interest and dividend income | $ | 2,437 | $ | 2,682 | $ | 3,990 | $ | 5,307 | |||||||||||||||
| Gain on sale and fair value mark-to-market on investments | 1,550 | 2,259 | 3,040 | 4,207 | |||||||||||||||||||
Fair value changes of contingent consideration (1) | (3,000) | — | (3,000) | — | |||||||||||||||||||
| Others, net | (857) | 730 | (1,509) | 860 | |||||||||||||||||||
| Other income, net | $ | 130 | $ | 5,671 | $ | 2,521 | $ | 10,374 | |||||||||||||||
| As of | |||||||||||||||||
| June 30, 2026 | June 30, 2025 | December 31, 2025 | |||||||||||||||
| Cash and cash equivalents | $ | 126,722 | $ | 149,134 | $ | 146,326 | |||||||||||
Restricted cash (current)(1) | 12,964 | 11,503 | 12,392 | ||||||||||||||
Restricted cash (non-current)(2) | 7,086 | 9,888 | 7,251 | ||||||||||||||
| Cash, cash equivalents and restricted cash | $ | 146,772 | $ | 170,525 | $ | 165,969 | |||||||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Short-term investments | |||||||||||
Mutual funds(1) | $ | 98,499 | $ | 129,549 | |||||||
| Term deposits | 58,603 | 52,492 | |||||||||
| Short-term investments | $ | 157,102 | $ | 182,041 | |||||||
| Long-term investments | |||||||||||
| Term deposits | $ | 255 | $ | 2,626 | |||||||
| Investment in equity affiliate | 6,141 | 5,572 | |||||||||
| Long-term investments | $ | 6,396 | $ | 8,198 | |||||||
| As of | ||||||||||||||
| June 30, 2026 | December 31, 2025 | |||||||||||||
| Property and equipment, gross | $ | 383,761 | $ | 367,558 | ||||||||||
| Less: Accumulated depreciation and amortization | (269,174) | (255,737) | ||||||||||||
| Property and equipment, net | $ | 114,587 | $ | 111,821 | ||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Depreciation and amortization expense | $ | 11,346 | $ | 10,778 | $ | 22,123 | $ | 21,089 | |||||||||||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Cost | $ | 66,051 | $ | 59,391 | |||||||
| Less: Accumulated amortization | (44,383) | (39,332) | |||||||||
| Internally developed software, net | $ | 21,668 | $ | 20,059 | |||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Amortization expense | $ | 2,628 | $ | 2,743 | $ | 5,051 | $ | 5,483 | |||||||||||||||
| Insurance | Healthcare and Life Sciences | Banking, Capital Markets and Diversified Industries | International Growth Markets | Total | |||||||||||||||||||||||||
| Balance as of December 31, 2025 | $ | 77,269 | $ | 189,594 | $ | 100,153 | $ | 52,638 | $ | 419,654 | |||||||||||||||||||
| Currency translation adjustments | (42) | (28) | (494) | (397) | (961) | ||||||||||||||||||||||||
| Balance as of June 30, 2026 | $ | 77,227 | $ | 189,566 | $ | 99,659 | $ | 52,241 | $ | 418,693 | |||||||||||||||||||
| As of June 30, 2026 | As of December 31, 2025 | ||||||||||||||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||||||||||
| Finite-lived intangible assets: | |||||||||||||||||||||||||||||||||||
| Customer relationships | $ | 108,550 | $ | (79,839) | $ | 28,711 | $ | 108,550 | $ | (73,482) | $ | 35,068 | |||||||||||||||||||||||
| Developed technology | 3,609 | (3,609) | — | 3,636 | (3,558) | 78 | |||||||||||||||||||||||||||||
| Trade names and trademarks | 1,700 | (1,591) | 109 | 1,700 | (1,542) | 158 | |||||||||||||||||||||||||||||
| Non-compete agreements | 300 | (300) | — | 300 | (300) | — | |||||||||||||||||||||||||||||
| 114,159 | (85,339) | 28,820 | 114,186 | (78,882) | 35,304 | ||||||||||||||||||||||||||||||
| Indefinite-lived intangible assets: | |||||||||||||||||||||||||||||||||||
| Trade names and trademarks | 900 | — | 900 | 900 | — | 900 | |||||||||||||||||||||||||||||
| Other intangible assets | $ | 115,059 | $ | (85,339) | $ | 29,720 | $ | 115,086 | $ | (78,882) | $ | 36,204 | |||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Amortization expense | $ | 3,258 | $ | 3,277 | $ | 6,484 | $ | 6,523 | |||||||||||||||
| 2026 (July 1 - December 31) | $ | 6,292 | |||
| 2027 | 11,844 | ||||
| 2028 | 9,228 | ||||
| 2029 | 1,456 | ||||
| Total | $ | 28,820 | |||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Contract assets | $ | 39,458 | $ | 27,083 | |||||||
| Prepaid expenses | 38,488 | 26,465 | |||||||||
| Advance income tax, net | 24,378 | 51,984 | |||||||||
| Receivables from statutory authorities | 22,476 | 21,374 | |||||||||
| Deferred contract fulfillment costs | 8,125 | 7,077 | |||||||||
| Derivative instruments | 3,433 | 4,640 | |||||||||
| Others | 7,774 | 7,470 | |||||||||
| Other current assets | $ | 144,132 | $ | 146,093 | |||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Deferred contract fulfillment costs | $ | 30,496 | $ | 32,146 | |||||||
| Prepaid expenses | 7,809 | 6,761 | |||||||||
| Deposits with statutory authorities | 7,494 | 7,859 | |||||||||
| Lease deposits | 7,314 | 7,087 | |||||||||
| Contract assets | 3,823 | 4,818 | |||||||||
| Derivative instruments | 1,050 | 1,424 | |||||||||
| Others | 1,354 | 1,676 | |||||||||
| Other assets | $ | 59,340 | $ | 61,771 | |||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Accrued expenses | $ | 70,620 | $ | 64,220 | |||||||
| Derivative instruments | 32,156 | 15,443 | |||||||||
| Payable to statutory authorities | 24,423 | 27,222 | |||||||||
| Client liabilities | 13,180 | 12,601 | |||||||||
| Contingent consideration | 8,000 | 5,000 | |||||||||
| Others | 13,146 | 11,012 | |||||||||
| Accrued expenses and other current liabilities | $ | 161,525 | $ | 135,498 | |||||||
| As of | |||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||
| Retirement benefits | $ | 41,507 | $ | 41,632 | |||||||
| Deferred transition revenue | 25,726 | 26,139 | |||||||||
| Derivative instruments | 16,344 | 9,765 | |||||||||
| Unrecognized tax benefits | 2,429 | 2,176 | |||||||||
| Others | 1,607 | 1,689 | |||||||||
| Other non-current liabilities | $ | 87,613 | $ | 81,401 | |||||||
| Accumulated Other Comprehensive Income/(Loss) | |||||||||||||||||||||||
| Currency translation adjustments | Unrealized gain/(loss) on cash flow hedges | Retirement benefits | Total | ||||||||||||||||||||
| Balance as of December 31, 2025 | $ | (156,548) | $ | (15,490) | $ | (8,689) | $ | (180,727) | |||||||||||||||
| Loss recognized during the period | (23,091) | (37,047) | (1,177) | (61,315) | |||||||||||||||||||
Reclassification to net income(1) | — | 12,729 | 743 | 13,472 | |||||||||||||||||||
Income tax effects(2) | — | 4,873 | 15 | 4,888 | |||||||||||||||||||
| Balance as of June 30, 2026 | $ | (179,639) | $ | (34,935) | $ | (9,108) | $ | (223,682) | |||||||||||||||
| Balance as of December 31, 2024 | $ | (146,998) | $ | (7,548) | $ | (176) | $ | (154,722) | |||||||||||||||
| Gain recognized during the period | 7,933 | 15,424 | — | 23,357 | |||||||||||||||||||
Reclassification to net income(1) | — | 1,044 | (228) | 816 | |||||||||||||||||||
Income tax effects(2) | (1,012) | (2,847) | (26) | (3,885) | |||||||||||||||||||
| Balance as of June 30, 2025 | $ | (140,077) | $ | 6,073 | $ | (430) | $ | (134,434) | |||||||||||||||
| Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Other Unobservable Inputs | |||||||||||||||||||||
| As of June 30, 2026 | (Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
Cash equivalents - Money market funds(1) | $ | 36,788 | $ | — | $ | — | $ | 36,788 | |||||||||||||||
Mutual funds(1) | 98,499 | — | — | 98,499 | |||||||||||||||||||
| Derivative financial instruments | — | 4,483 | — | 4,483 | |||||||||||||||||||
| Total | $ | 135,287 | $ | 4,483 | $ | — | $ | 139,770 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Derivative financial instruments | $ | — | $ | 48,500 | $ | — | $ | 48,500 | |||||||||||||||
Contingent consideration(2) | — | — | 8,000 | 8,000 | |||||||||||||||||||
| Total | $ | — | $ | 48,500 | $ | 8,000 | $ | 56,500 | |||||||||||||||
| Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Other Unobservable Inputs | |||||||||||||||||||||
| As of December 31, 2025 | (Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
Cash equivalents - Money market funds(1) | $ | 50,971 | $ | — | $ | — | $ | 50,971 | |||||||||||||||
Mutual funds(1) | 129,549 | — | — | 129,549 | |||||||||||||||||||
| Derivative financial instruments | — | 6,064 | — | 6,064 | |||||||||||||||||||
| Total | $ | 180,520 | $ | 6,064 | $ | — | $ | 186,584 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Derivative financial instruments | $ | — | $ | 25,208 | $ | — | $ | 25,208 | |||||||||||||||
Contingent consideration(2) | — | — | 5,000 | 5,000 | |||||||||||||||||||
| Total | $ | — | $ | 25,208 | $ | 5,000 | $ | 30,208 | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Opening balance | $ | 5,000 | $ | 2,700 | $ | 5,000 | $ | 2,700 | |||||||||||||||
| Fair value changes | 3,000 | — | 3,000 | — | |||||||||||||||||||
| Payments | — | — | — | — | |||||||||||||||||||
| Closing balance | $ | 8,000 | $ | 2,700 | $ | 8,000 | $ | 2,700 | |||||||||||||||
| As of | ||||||||||||||
| June 30, 2026 | December 31, 2025 | |||||||||||||
| Foreign currency forward contracts denominated in: | ||||||||||||||
| Sell U.S. dollar (USD) | 992,400 | 1,134,800 | ||||||||||||
| Buy U.S. dollar (USD) | 5,159 | 12,075 | ||||||||||||
| As of | ||||||||||||||
| Foreign currency forward contracts denominated in: | June 30, 2026 | December 31, 2025 | ||||||||||||
| Sell USD | 244,088 | 217,040 | ||||||||||||
| Sell GBP | 27,880 | 35,962 | ||||||||||||
| Sell EUR | 7,376 | 7,722 | ||||||||||||
| Sell AUD | 4,619 | 4,917 | ||||||||||||
| Buy USD | 3,176 | 1,837 | ||||||||||||
| Derivatives in cash flow hedging relationships | Derivatives not designated as hedging instruments | |||||||||||||||||||||||||
| As of | As of | |||||||||||||||||||||||||
| June 30, 2026 | December 31, 2025 | June 30, 2026 | December 31, 2025 | |||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Other current assets | $ | 3,419 | $ | 4,444 | $ | 14 | $ | 196 | ||||||||||||||||||
| Other assets | $ | 1,050 | $ | 1,424 | $ | — | $ | — | ||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||
| Accrued expenses and other current liabilities | $ | 31,723 | $ | 15,383 | $ | 433 | $ | 60 | ||||||||||||||||||
| Other non-current liabilities | $ | 16,344 | $ | 9,765 | $ | — | $ | — | ||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | |||||||||||||||||||||||||
| Derivative financial instruments: | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||
| Unrealized gain/(loss) recognized in other comprehensive income (“OCI”) | ||||||||||||||||||||||||||
| Derivatives in cash flow hedging relationships | $ | 8,888 | $ | 5,955 | $ | (37,047) | $ | 15,424 | ||||||||||||||||||
| Gain/(loss) recognized in unaudited consolidated statements of income | ||||||||||||||||||||||||||
| Derivatives not designated as hedging instruments | $ | 1,747 | $ | (1,766) | $ | (8,714) | $ | (1,286) | ||||||||||||||||||
| Three months ended June 30, | ||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||
| As per unaudited consolidated statements of income | Gain/(loss) on derivative financial instruments | As per unaudited consolidated statements of income | Gain/(loss) on derivative financial instruments | |||||||||||||||||||||||
| Derivatives in cash flow hedging relationships | ||||||||||||||||||||||||||
| Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | ||||||||||||||||||||||||||
| Revenues, net | $ | 594,763 | $ | 319 | $ | 514,460 | $ | (1,028) | ||||||||||||||||||
| Cost of revenues | $ | 368,800 | (7,043) | $ | 320,272 | 1,360 | ||||||||||||||||||||
| General and administrative expenses | $ | 74,436 | (841) | $ | 59,549 | 126 | ||||||||||||||||||||
| Selling and marketing expenses | $ | 49,628 | (115) | $ | 39,446 | 7 | ||||||||||||||||||||
| Depreciation and amortization expense | $ | 14,604 | (127) | $ | 14,055 | 89 | ||||||||||||||||||||
| Total before tax | (7,807) | 554 | ||||||||||||||||||||||||
| Income tax effects on above | 1,575 | (165) | ||||||||||||||||||||||||
| Net of tax | $ | (6,232) | $ | 389 | ||||||||||||||||||||||
| Derivatives not designated as hedging instruments | ||||||||||||||||||||||||||
| Location in unaudited consolidated statements of income where gain/(loss) was recognized | ||||||||||||||||||||||||||
| Foreign exchange gain, net | $ | 1,609 | $ | 1,747 | $ | 2,211 | $ | (1,766) | ||||||||||||||||||
| Six months ended June 30, | ||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||
| As per unaudited consolidated statements of income | Gain/(loss) on derivative financial instruments | As per unaudited consolidated statements of income | Gain/(loss) on derivative financial instruments | |||||||||||||||||||||||
| Derivatives in cash flow hedging relationships | ||||||||||||||||||||||||||
| Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | ||||||||||||||||||||||||||
| Revenues, net | $ | 1,165,114 | 139 | $ | 1,015,479 | $ | (1,028) | |||||||||||||||||||
| Cost of revenues | $ | 717,070 | (11,178) | $ | 627,977 | (53) | ||||||||||||||||||||
| General and administrative expenses | $ | 143,487 | (1,368) | $ | 118,966 | (28) | ||||||||||||||||||||
| Selling and marketing expenses | $ | 96,829 | (187) | $ | 81,371 | (9) | ||||||||||||||||||||
| Depreciation and amortization expense | $ | 28,607 | (135) | $ | 27,612 | 74 | ||||||||||||||||||||
| Total before tax | (12,729) | (1,044) | ||||||||||||||||||||||||
| Income tax effects on above | 2,667 | 217 | ||||||||||||||||||||||||
| Net of tax | $ | (10,062) | $ | (827) | ||||||||||||||||||||||
| Derivatives not designated as hedging instruments | ||||||||||||||||||||||||||
| Location in unaudited consolidated statements of income where gain/(loss) was recognized | ||||||||||||||||||||||||||
| Foreign exchange gain, net | $ | 2,744 | $ | (8,714) | $ | 3,403 | $ | (1,286) | ||||||||||||||||||
| As of | |||||||||||||||||||||||||||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||||||||||||||||||||||||||
| Revolving credit facility | Term loan facility | Total | Revolving credit facility | Term loan facility | Total | ||||||||||||||||||||||||||||||
| Current portion of long-term borrowings | $ | 290,000 | $ | 91,250 | $ | 381,250 | $ | — | $ | 5,000 | $ | 5,000 | |||||||||||||||||||||||
| Unamortized debt issuance costs | — | (95) | (95) | — | (114) | (114) | |||||||||||||||||||||||||||||
| Current portion of long-term borrowings | 290,000 | 91,155 | 381,155 | — | 4,886 | 4,886 | |||||||||||||||||||||||||||||
| Long-term borrowings | — | — | — | 205,000 | 88,750 | 293,750 | |||||||||||||||||||||||||||||
| Unamortized debt issuance costs | — | — | — | — | (38) | (38) | |||||||||||||||||||||||||||||
| Long-term borrowings | — | — | — | 205,000 | 88,712 | 293,712 | |||||||||||||||||||||||||||||
| Borrowings | $ | 290,000 | $ | 91,155 | $ | 381,155 | $ | 205,000 | $ | 93,598 | $ | 298,598 | |||||||||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revolving credit facility | 5.0 | % | 5.8 | % | 5.0 | % | 5.8 | % | |||||||||||||||
| Term loan facility | 5.1 | % | 5.7 | % | 5.1 | % | 5.7 | % | |||||||||||||||
| Revolving credit facility | Term loan facility | ||||||||||
| 2026 (July 1 - December 31) | $ | — | $ | 2,500 | |||||||
| 2027 | 290,000 | 88,750 | |||||||||
| Total | $ | 290,000 | $ | 91,250 | |||||||
| Shares repurchased | Total consideration | Weighted average purchase price per share (1) | |||||||||||||||
| Three months ended June 30, 2026 | — | $ | — | $ | — | ||||||||||||
| Three months ended June 30, 2025 | — | $ | — | $ | — | ||||||||||||
| Six months ended June 30, 2026 | 129,695 | $ | 4,847 | $ | 37.37 | ||||||||||||
| Six months ended June 30, 2025 | 190,716 | $ | 9,432 | $ | 49.46 | ||||||||||||
| Shares repurchased | Total consideration | Weighted average purchase price per share | |||||||||||||||
| Three months ended June 30, 2026 | 1,426,474 | $ | 43,451 | $ | 30.46 | ||||||||||||
| Three months ended June 30, 2025 | 906,150 | $ | 41,752 | $ | 46.08 | ||||||||||||
| Six months ended June 30, 2026 | 5,801,580 | $ | 179,254 | $ | 30.90 | ||||||||||||
| Six months ended June 30, 2025 | 1,081,213 | $ | 49,811 | $ | 46.07 | ||||||||||||
| Change in Plan Assets | ||||||||
| Plan assets as of December 31, 2025 | $ | 24,358 | ||||||
| Actual return | 1,030 | |||||||
| Employer contribution | 2,852 | |||||||
| Benefits paid | (1,329) | |||||||
| Currency translation adjustments | (1,230) | |||||||
Plan assets as of June 30, 2026 | $ | 25,681 | ||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Service cost | $ | 1,987 | $ | 1,406 | $ | 4,010 | $ | 2,789 | |||||||||||||||
| Interest cost | 712 | 517 | 1,441 | 1,026 | |||||||||||||||||||
| Expected return on plan assets | (404) | (351) | (817) | (696) | |||||||||||||||||||
| Reclassification of retirement benefits from AOCI: | |||||||||||||||||||||||
| Amortization of actuarial gain | (161) | (117) | (344) | (228) | |||||||||||||||||||
| Amortization of prior service cost | 566 | — | 1,087 | — | |||||||||||||||||||
| Net periodic benefit cost | $ | 2,700 | $ | 1,455 | $ | 5,377 | $ | 2,891 | |||||||||||||||
| Reclassification of retirement benefits from AOCI, gross of tax | $ | 405 | $ | (117) | $ | 743 | $ | (228) | |||||||||||||||
| Income tax effects | (150) | (13) | (281) | (26) | |||||||||||||||||||
| Reclassification of retirement benefits from AOCI, net of tax | $ | 255 | $ | (130) | $ | 462 | $ | (254) | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Contribution to the 401(k) Plans | $ | 1,504 | $ | 1,376 | $ | 4,522 | $ | 4,171 | |||||||||||||||
Contributions to the defined contribution plans in foreign subsidiaries of the Company | $ | 9,153 | $ | 8,692 | $ | 18,060 | $ | 16,477 | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Finance lease: | |||||||||||||||||||||||
| Depreciation on underlying ROU assets | $ | 174 | $ | 147 | $ | 337 | $ | 279 | |||||||||||||||
| Interest on lease liabilities | 54 | 77 | 134 | 146 | |||||||||||||||||||
| 228 | 224 | 471 | 425 | ||||||||||||||||||||
Operating lease(1) | 7,225 | 6,528 | 14,265 | 12,707 | |||||||||||||||||||
| Variable lease costs | 1,274 | 1,214 | 2,359 | 2,287 | |||||||||||||||||||
| Sublease income | — | (113) | — | (223) | |||||||||||||||||||
| Total lease cost | $ | 8,727 | $ | 7,853 | $ | 17,095 | $ | 15,196 | |||||||||||||||
| Six months ended June 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash payments for amounts included in the measurement of lease liabilities: | |||||||||||
| Operating cash outflows for operating leases | $ | 12,042 | $ | 12,250 | |||||||
| Operating cash outflows for finance leases | $ | 134 | $ | 77 | |||||||
| Financing cash outflows for finance leases | $ | 277 | $ | 247 | |||||||
| ROU assets obtained in exchange for new operating lease liabilities | $ | 12,202 | $ | 12,332 | |||||||
| ROU assets obtained in exchange for new finance lease liabilities | $ | 383 | $ | 633 | |||||||
| Weighted average remaining lease term (in years) | |||||||||||
| Finance lease | 2.3 years | 2.4 years | |||||||||
| Operating lease | 6.5 years | 4.7 years | |||||||||
| Weighted average discount rate | |||||||||||
| Finance lease | 14.9 | % | 15.1 | % | |||||||
| Operating lease | 7.6 | % | 8.0 | % | |||||||
| Operating Leases | Finance Leases | ||||||||||
| 2026 (July 1 - December 31) | $ | 13,112 | $ | 946 | |||||||
| 2027 | 26,421 | 812 | |||||||||
| 2028 | 23,919 | 580 | |||||||||
| 2029 | 15,801 | 309 | |||||||||
| 2030 | 11,440 | 82 | |||||||||
| 2031 and thereafter | 44,411 | — | |||||||||
| Total lease payments | 135,104 | 2,729 | |||||||||
| Less: Imputed interest | 28,240 | 582 | |||||||||
| Present value of lease liabilities | $ | 106,864 | $ | 2,147 | |||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Deferred taxes benefit / (expense) recognized on: | |||||||||||||||||||||||
| Unrealized gain/(loss) on cash flow hedges | $ | (2,396) | $ | (750) | $ | 7,540 | $ | (2,630) | |||||||||||||||
| Reclassification adjustment for cash flow hedges | (1,575) | 165 | (2,667) | (217) | |||||||||||||||||||
| Retirement benefits | — | — | 296 | — | |||||||||||||||||||
| Reclassification adjustment for retirement benefits | (150) | (13) | (281) | (26) | |||||||||||||||||||
| Currency translation adjustments | — | (339) | — | (1,012) | |||||||||||||||||||
| Total | $ | (4,121) | $ | (937) | $ | 4,888 | $ | (3,885) | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Cost of revenues | $ | 3,577 | $ | 3,421 | $ | 6,593 | $ | 6,908 | |||||||||||||||
| General and administrative expenses | 10,708 | 6,617 | 20,031 | 13,803 | |||||||||||||||||||
| Selling and marketing expenses | 10,346 | 6,354 | 20,108 | 14,868 | |||||||||||||||||||
| Total | $ | 24,631 | $ | 16,392 | $ | 46,732 | $ | 35,579 | |||||||||||||||
Income tax benefit related to share-based compensation(1) | $ | 6,097 | $ | 4,211 | $ | 7,413 | $ | 13,316 | |||||||||||||||
Number of Options | Weighted Average Exercise Price | Aggregate Intrinsic Value | Weighted Average Remaining Contractual Life (Years) | ||||||||||||||||||||
| Outstanding as of December 31, 2025 | 1,734,720 | $ | 30.14 | $ | 21,344 | 7.5 | |||||||||||||||||
| Granted | — | — | — | — | |||||||||||||||||||
| Exercised | — | — | — | — | |||||||||||||||||||
| Forfeited | — | — | — | — | |||||||||||||||||||
| Outstanding as of June 30, 2026 | 1,734,720 | $ | 30.14 | $ | — | 7.0 | |||||||||||||||||
| Vested and exercisable as of June 30, 2026 | 1,264,700 | $ | 30.14 | $ | — | 7.0 | |||||||||||||||||
Weighted average grant date fair value of per unit of stock option granted during the period | $ | — | |||||||||||||||||||||
| Restricted Stock Units | |||||||||||
| Number | Weighted Average Fair Value | ||||||||||
Outstanding as of December 31, 2025(1) | 2,789,601 | $ | 37.65 | ||||||||
| Granted | 1,653,889 | 30.83 | |||||||||
| Vested | (1,047,510) | 34.64 | |||||||||
| Forfeited | (116,947) | 36.36 | |||||||||
Outstanding as of June 30, 2026(1) | 3,279,033 | $ | 35.22 | ||||||||
| Revenue Based PRSUs | Market Condition Based PRSUs | ||||||||||||||||||||||
| Number | Weighted Average Fair Value | Number | Weighted Average Fair Value | ||||||||||||||||||||
| Outstanding as of December 31, 2025 | 696,439 | $ | 39.20 | 841,966 | $ | 56.31 | |||||||||||||||||
| Granted | 409,256 | 30.90 | 613,778 | 36.42 | |||||||||||||||||||
| Vested | — | — | — | — | |||||||||||||||||||
| Forfeited | (15,147) | 37.03 | (22,710) | 53.63 | |||||||||||||||||||
| Outstanding as of June 30, 2026 | 1,090,548 | $ | 36.12 | 1,433,034 | $ | 47.83 | |||||||||||||||||
| Number | Total Proceeds Received | |||||||||||||
| Shares available for issuance as of December 31, 2025 | 3,510,269 | |||||||||||||
| Issuance of common stock made during the seventh offering period | 60,139 | $ | 2,297 | |||||||||||
| Shares available for issuance as of June 30, 2026 | 3,450,130 | |||||||||||||
| Issuance of common stock related to the eighth offering period made subsequent to June 30, 2026 | 146,650 | $ | 3,413 | |||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||
| Three months ended June 30, 2026 | Percentage of Revenues, net | Three months ended June 30, 2025 | Percentage of Revenues, net | Dollar change | Percentage change | ||||||||||||||||||||||||||||||
| (A) | (B) | (C=A-B) | |||||||||||||||||||||||||||||||||
| Revenues, net | $ | 594.8 | 100.0 | % | $ | 514.5 | 100.0 | % | $ | 80.3 | 15.6 | % | |||||||||||||||||||||||
Cost of revenues (1) | 368.8 | 62.0 | % | 320.3 | 62.3 | % | 48.5 | 15.2 | % | ||||||||||||||||||||||||||
Gross profit (1) | 226.0 | 38.0 | % | 194.2 | 37.7 | % | 31.8 | 16.4 | % | ||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||
| General and administrative expenses | 74.4 | 12.5 | % | 59.5 | 11.6 | % | 14.9 | 25.0 | % | ||||||||||||||||||||||||||
| Selling and marketing expenses | 49.6 | 8.3 | % | 39.4 | 7.7 | % | 10.2 | 25.8 | % | ||||||||||||||||||||||||||
| Depreciation and amortization expense | 14.6 | 2.5 | % | 14.1 | 2.7 | % | 0.5 | 3.9 | % | ||||||||||||||||||||||||||
| Total operating expenses | 138.6 | 23.3 | % | 113.0 | 22.0 | % | 25.6 | 22.7 | % | ||||||||||||||||||||||||||
| Income from operations | 87.4 | 14.7 | % | 81.2 | 15.8 | % | 6.2 | 7.6 | % | ||||||||||||||||||||||||||
| Foreign exchange gain, net | 1.6 | 0.3 | % | 2.2 | 0.4 | % | (0.6) | (27.2) | % | ||||||||||||||||||||||||||
| Interest expense | (5.1) | (0.9) | % | (4.3) | (0.8) | % | (0.8) | 18.4 | % | ||||||||||||||||||||||||||
| Other income, net | 0.1 | — | % | 5.7 | 1.1 | % | (5.6) | (97.7) | % | ||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | 84.0 | 14.1 | % | 84.8 | 16.5 | % | (0.8) | (0.9) | % | ||||||||||||||||||||||||||
| Income tax expense | 19.4 | 3.3 | % | 18.6 | 3.6 | % | 0.8 | 4.7 | % | ||||||||||||||||||||||||||
| Income before earnings from equity affiliates | 64.6 | 10.9 | % | 66.2 | 12.9 | % | (1.6) | (2.5) | % | ||||||||||||||||||||||||||
| Loss from equity-method investment | — | — | % | (0.1) | — | % | 0.1 | — | % | ||||||||||||||||||||||||||
| Net income | $ | 64.6 | 10.8 | % | $ | 66.1 | 12.8 | % | $ | (1.5) | (2.3) | % | |||||||||||||||||||||||
| Cost of Revenues | Gross Margin | ||||||||||||||||||||||||||||||||||||||||
| Three months ended June 30, | Dollar change | Percentage change | Three months ended June 30, | Percentage change | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||||||||
| Insurance | $ | 129.4 | $ | 112.3 | $ | 17.1 | 15.2 | % | 34.6 | % | 34.8 | % | (0.2) | % | |||||||||||||||||||||||||||
| Healthcare and Life Sciences | 83.9 | 73.1 | 10.8 | 14.8 | % | 46.9 | % | 43.5 | % | 3.4 | % | ||||||||||||||||||||||||||||||
| Banking, Capital Markets and Diversified Industries | 87.3 | 75.4 | 11.9 | 15.8 | % | 34.8 | % | 37.8 | % | (3.0) | % | ||||||||||||||||||||||||||||||
| International Growth Markets | 68.2 | 59.5 | 8.7 | 14.7 | % | 35.1 | % | 35.1 | % | — | % | ||||||||||||||||||||||||||||||
| Total | $ | 368.8 | $ | 320.3 | $ | 48.5 | 15.2 | % | 38.0 | % | 37.7 | % | 0.3 | % | |||||||||||||||||||||||||||
| Three months ended June 30, | Change | Percentage change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Interest and dividend income | $ | 2.4 | $ | 2.7 | $ | (0.3) | (9.1) | % | |||||||||||||||
| Gain on sale and fair value mark-to-market on investments | 1.6 | 2.3 | (0.7) | (31.4) | % | ||||||||||||||||||
| Fair value changes of contingent consideration | (3.0) | — | (3.0) | (100.0) | % | ||||||||||||||||||
| Others, net | (0.9) | 0.7 | (1.6) | (217.4) | % | ||||||||||||||||||
| Other income, net | $ | 0.1 | $ | 5.7 | $ | (5.6) | (97.7) | % | |||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||
| Six months ended June 30, 2026 | Percentage of Revenues, net | Six months ended June 30, 2025 | Percentage of Revenues, net | Dollar Change | Percentage Change | ||||||||||||||||||||||||||||||
| (A) | (B) | (C=A-B) | |||||||||||||||||||||||||||||||||
| Revenues, net | $ | 1,165.1 | 100.0 | % | $ | 1,015.5 | 100.0 | % | $ | 149.6 | 14.7 | % | |||||||||||||||||||||||
Cost of revenues (1) | 717.1 | 61.5 | % | 628.0 | 61.8 | % | 89.1 | 14.2 | % | ||||||||||||||||||||||||||
Gross profit (1) | 448.0 | 38.5 | % | 387.5 | 38.2 | % | 60.5 | 15.6 | % | ||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||
| General and administrative expenses | 143.5 | 12.3 | % | 119.0 | 11.7 | % | 24.5 | 20.6 | % | ||||||||||||||||||||||||||
| Selling and marketing expenses | 96.8 | 8.3 | % | 81.4 | 8.0 | % | 15.4 | 19.0 | % | ||||||||||||||||||||||||||
| Depreciation and amortization expense | 28.6 | 2.5 | % | 27.6 | 2.7 | % | 1.0 | 3.6 | % | ||||||||||||||||||||||||||
| Total operating expenses | 268.9 | 23.1 | % | 228.0 | 22.4 | % | 40.9 | 18.0 | % | ||||||||||||||||||||||||||
| Income from operations | 179.1 | 15.4 | % | 159.5 | 15.7 | % | 19.6 | 12.3 | % | ||||||||||||||||||||||||||
| Foreign exchange gain, net | 2.7 | 0.2 | % | 3.4 | 0.3 | % | (0.7) | (19.4) | % | ||||||||||||||||||||||||||
| Interest expense | (9.0) | (0.8) | % | (8.4) | (0.8) | % | (0.6) | 7.0 | % | ||||||||||||||||||||||||||
| Other income, net | 2.5 | 0.2 | % | 10.4 | 1.0 | % | (7.9) | (75.7) | % | ||||||||||||||||||||||||||
| Income before income tax expense and earnings from equity affiliates | 175.3 | 15.1 | % | 164.9 | 16.2 | % | 10.4 | 6.3 | % | ||||||||||||||||||||||||||
| Income tax expense | 43.7 | 3.8 | % | 32.0 | 3.2 | % | 11.7 | 36.5 | % | ||||||||||||||||||||||||||
| Income before earnings from equity affiliates | 131.6 | 11.3 | % | 132.9 | 13.1 | % | (1.3) | (0.9) | % | ||||||||||||||||||||||||||
| Loss from equity-method investment | — | — | % | (0.3) | — | % | 0.3 | (87.6) | % | ||||||||||||||||||||||||||
| Net income | $ | 131.6 | 11.3 | % | $ | 132.6 | 13.1 | % | $ | (1.0) | (0.8) | % | |||||||||||||||||||||||
| Six months ended June 30, | Dollar change | Percentage change | Percentage of Total Revenues for the six months ended June 30, | ||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||
| Insurance | $ | 391.7 | $ | 344.2 | $ | 47.5 | 13.8 | % | 33.6 | % | 33.9 | % | |||||||||||||||||||||||
| Healthcare and Life Sciences | 309.9 | 255.1 | 54.8 | 21.5 | % | 26.6 | % | 25.1 | % | ||||||||||||||||||||||||||
| Banking, Capital Markets and Diversified Industries | 261.2 | 238.8 | 22.4 | 9.4 | % | 22.4 | % | 23.5 | % | ||||||||||||||||||||||||||
| International Growth Markets | 202.3 | 177.4 | 24.9 | 14.0 | % | 17.4 | % | 17.5 | % | ||||||||||||||||||||||||||
| Revenues, net | $ | 1,165.1 | $ | 1,015.5 | $ | 149.6 | 14.7 | % | 100.0 | % | 100.0 | % | |||||||||||||||||||||||
| Cost of Revenues | Gross Margin | ||||||||||||||||||||||||||||||||||||||||
| Six months ended June 30, | Dollar change | Percentage change | Six months ended June 30, | Percentage change | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||||||||
| Insurance | $ | 250.2 | $ | 221.5 | $ | 28.7 | 13.0 | % | 36.1 | % | 35.7 | % | 0.4 | % | |||||||||||||||||||||||||||
| Healthcare and Life Sciences | 167.0 | 143.6 | 23.4 | 16.3 | % | 46.1 | % | 43.7 | % | 2.4 | % | ||||||||||||||||||||||||||||||
| Banking, Capital Markets and Diversified Industries | 167.7 | 149.1 | 18.6 | 12.4 | % | 35.8 | % | 37.6 | % | (1.8) | % | ||||||||||||||||||||||||||||||
| International Growth Markets | 132.2 | 113.8 | 18.4 | 16.2 | % | 34.6 | % | 35.9 | % | (1.3) | % | ||||||||||||||||||||||||||||||
| Total | $ | 717.1 | $ | 628.0 | $ | 89.1 | 14.2 | % | 38.5 | % | 38.2 | % | 0.3 | % | |||||||||||||||||||||||||||
| Six months ended June 30, | Change | Percentage change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Interest and dividend income | $ | 4.0 | $ | 5.3 | $ | (1.3) | (24.8) | % | |||||||||||||||
| Gain on sale and fair value mark-to-market on investments | 3.0 | 4.2 | (1.2) | (27.7) | % | ||||||||||||||||||
| Fair value changes of contingent consideration | (3.0) | — | (3.0) | (100.0) | % | ||||||||||||||||||
| Others, net | (1.5) | 0.9 | (2.4) | (275.5) | % | ||||||||||||||||||
| Other income, net | $ | 2.5 | $ | 10.4 | $ | (7.9) | (75.7) | % | |||||||||||||||
| Six months ended June 30, | Dollar Change | Percentage Change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Opening cash, cash equivalents and restricted cash | $ | 166.0 | $ | 171.4 | $ | (5.4) | (3.2) | % | |||||||||||||||
| Net cash provided by operating activities | 89.6 | 112.6 | (23.0) | (20.4) | % | ||||||||||||||||||
| Net cash used for investing activities | (6.2) | (36.3) | 30.1 | (83.0) | % | ||||||||||||||||||
| Net cash used for financing activities | (100.8) | (84.6) | (16.2) | 19.2 | % | ||||||||||||||||||
| Effect of exchange rate changes | (1.8) | 7.4 | (9.2) | (125.3) | % | ||||||||||||||||||
| Closing cash, cash equivalents and restricted cash | $ | 146.8 | $ | 170.5 | $ | (23.7) | (13.9) | % | |||||||||||||||
| As of | |||||||||||||||||||||||||||||||||||
| June 30, 2026 | December 31, 2025 | ||||||||||||||||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||||||||||||||
| Revolving credit facility | Term loan facility | Total | Revolving credit facility | Term loan facility | Total | ||||||||||||||||||||||||||||||
| Current portion of long-term borrowings | $ | 290.0 | $ | 91.3 | $ | 381.3 | $ | — | $ | 5.0 | $ | 5.0 | |||||||||||||||||||||||
| Unamortized debt issuance costs | — | (0.1) | (0.1) | — | (0.1) | (0.1) | |||||||||||||||||||||||||||||
| Current portion of long-term borrowings | 290.0 | 91.2 | 381.2 | — | 4.9 | 4.9 | |||||||||||||||||||||||||||||
| Long-term borrowings | — | — | — | 205.0 | 88.8 | 293.8 | |||||||||||||||||||||||||||||
| Unamortized debt issuance costs | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Long-term borrowings | — | — | — | 205.0 | 88.8 | 293.8 | |||||||||||||||||||||||||||||
| Borrowings | $ | 290.0 | $ | 91.2 | $ | 381.2 | $ | 205.0 | $ | 93.7 | $ | 298.7 | |||||||||||||||||||||||
| Shares Purchased from Employees in connection with satisfaction of Withholding Tax Obligations | Shares Purchased as Part of Publicly Announced Programs | Total Number of Shares Purchased | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||||||||||||||||||
| Period | Number of Shares Purchased | Average Price Paid per share | Number of Shares Purchased | Average Price Paid per share | ||||||||||||||||||||||||||||||||||
April 1, 2026 through April 30, 2026 | — | $ | — | 277,745 | $ | 30.77 | 277,745 | $ | 360,000,038 | |||||||||||||||||||||||||||||
May 1, 2026 through May 31, 2026 | — | $ | — | 922,413 | $ | 30.94 | 922,413 | $ | 356,460,324 | |||||||||||||||||||||||||||||
June 1, 2026 through June 30, 2026 | — | $ | — | 226,316 | $ | 28.12 | 226,316 | $ | 350,095,275 | |||||||||||||||||||||||||||||
| Total | — | $ | — | 1,426,474 | $ | 30.46 | 1,426,474 | |||||||||||||||||||||||||||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101.INS | Inline XBRL Instance Document | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |||||||
| 101.PRE | Inline XBRL Extension Presentation Linkbase | |||||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | |||||||
| Date: July 28, 2026 | EXLSERVICE HOLDINGS, INC. | ||||||||||
| By: | /S/ MAURIZIO NICOLELLI | ||||||||||
| MAURIZIO NICOLELLI Chief Financial Officer (Duly Authorized Signatory, Principal Financial and Accounting Officer) | |||||||||||
| Date: July 28, 2026 | /s/ Rohit Kapoor | ||||
| Rohit Kapoor | |||||
| Chairman and Chief Executive Officer | |||||
| Date: July 28, 2026 | /s/ Maurizio Nicolelli | ||||
| Maurizio Nicolelli | |||||
| Chief Financial Officer | |||||
| /s/ Rohit Kapoor | |||||
| Rohit Kapoor | |||||
| Chairman and Chief Executive Officer | |||||
| July 28, 2026 | |||||
| /s/ Maurizio Nicolelli | |||||
| Maurizio Nicolelli | |||||
| Chief Financial Officer | |||||
| July 28, 2026 | |||||